In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL

Show simple item record

dc.contributor.author Laukkanen, S.
dc.contributor.author Gronroos, T.
dc.contributor.author Polonen, P.
dc.contributor.author Kuusanmaki, H.
dc.contributor.author Mehtonen, J.
dc.contributor.author Cloos, J.
dc.contributor.author Ossenkoppele, G.
dc.contributor.author Gjertsen, B.
dc.contributor.author Oystein, B.
dc.contributor.author Heckman, C.
dc.contributor.author Heinaniemi, M.
dc.contributor.author Kontro, M.
dc.contributor.author Lohi, O.
dc.date.accessioned 2017-09-21T10:00:02Z
dc.date.available 2017-09-21T10:00:02Z
dc.date.issued 2017-09-08
dc.identifier.citation Laukkanen , S , Gronroos , T , Polonen , P , Kuusanmaki , H , Mehtonen , J , Cloos , J , Ossenkoppele , G , Gjertsen , B , Oystein , B , Heckman , C , Heinaniemi , M , Kontro , M & Lohi , O 2017 , ' In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL ' , Blood cancer journal , vol. 7 , 604 . https://doi.org/10.1038/bcj.2017.87
dc.identifier.other PURE: 89973290
dc.identifier.other PURE UUID: 076cb1a5-7f4c-4d65-a5b7-925d22c87283
dc.identifier.other WOS: 000409990800002
dc.identifier.other Scopus: 85044637018
dc.identifier.uri http://hdl.handle.net/10138/224428
dc.format.extent 4
dc.language.iso eng
dc.relation.ispartof Blood cancer journal
dc.rights cc_by
dc.rights.uri info:eu-repo/semantics/openAccess
dc.subject ACUTE LYMPHOBLASTIC-LEUKEMIA
dc.subject CELL-ACTIVATION
dc.subject KINASE INHIBITOR
dc.subject SENSITIVITY
dc.subject EXPERIENCE
dc.subject REMISSION
dc.subject PATIENT
dc.subject LCK
dc.subject 3122 Cancers
dc.title In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL en
dc.type Article
dc.contributor.organization Institute for Molecular Medicine Finland
dc.contributor.organization University of Helsinki
dc.contributor.organization Clinicum
dc.contributor.organization Hematologian yksikkö
dc.contributor.organization Department of Oncology
dc.contributor.organization HUS Comprehensive Cancer Center
dc.description.reviewstatus Peer reviewed
dc.relation.doi https://doi.org/10.1038/bcj.2017.87
dc.relation.issn 2044-5385
dc.rights.accesslevel openAccess
dc.type.version publishedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
bcj201787a.pdf 669.6Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record